Characteristics of clinical molecular-genetic testing laboratories in the United States

Clinical Chemistry

Volumn 45, Issue 8 I, 1999, Pages 1288-1290

  Hofgartner W T ^a,c   Tait, J F ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCREDITATION; ARTICLE; CERTIFICATION; CLINICAL LABORATORY; CYSTIC FIBROSIS; FRAGILE X SYNDROME; GENETIC DISORDER; GOOD LABORATORY PRACTICE; HEALTH CARE FACILITY; MOLECULAR GENETICS; NON PROFIT HOSPITAL; PRACTICE GUIDELINE; PRIVATE HOSPITAL; QUESTIONNAIRE; UNITED STATES; UNIVERSITY HOSPITAL;

EID: 18144439353     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.8.1288     Document Type: Article

References (13)

1. Milunsky A. Threatened survival of academic-based genetic laboratory services [Letter]. Am J Hum Genet 1992;50:643-5.
2. Milunsky A. Commercialization of clinical genetic laboratory services: in whose best interest? Obstet Gynecol 1993;81:627-9.
3. Trigg ME, Geier MR. On the relationship between academic and private genetic services [Letter]. Am J Hum Genet 1992;51:890-1.
4. Warren RJ. Survival of academic-based genetic laboratory services [Letter]. Am J Hum Genet 1992;51:892-3.
5. Murphy P, Amos J, Carpenter N, Fenwick R, Hodes ME, Kelly T, et al. Minimum qualifications for directors: DNA-based genetic-testing laboratories. DNA Testing Subcommittee, Quality Assurance Committee, Council of Regional Networks for Genetic Services [Letter]. Am J Hum Genet 1992;51: 910-2.
6. Weaver DD, Baker D, Theobald M, Cohen F, King RA, Krueger S, et al. Minimum guidelines for the delivery of clinical genetics services. The Evaluation of Clinical Services Subcommittee, Great Lakes Regional Genetics Group [Letter]. Am J Hum Genet 1993;53:287-9.
7. Amos J, Gold B. Testing environment for single-gene disorders in US reference laboratories. Hum Mutat 1998;12:293-300.
8. Hofgārtner WT, Tait JF. Frequency of problems during clinical molecular genetic testing. Am J Clin Pathol 1999;112:14-21.
9. Holtzman NA, Hilgartner S, Brierley Bowers K, Tambor ES. Survey of biotechnology companies (BTCs) and molecular and cytogenetics laboratories (LABs) on genetic testing [Abstract]. Am J Hum Genet 1995;57(Suppl):A3.
10. Mark HF, Prence E, Beauregard L, Greenstein R. The impact of managed care on genetic testing laboratories in the United States. Cytobios 1996; 88:43-52.
11. McGovern MM, Benach MO, Wallenstein S, Desnick RJ, Keenlyside R. Quality assurance in molecular genetic testing laboratories. JAMA 1999; 281:835-40.
12. Grody WW, Pyeritz RE. Report card on molecular genetic testing: room for improvement? [Editorial]. JAMA 1999;281:845-7.
13. Press R, Wasserman L, Ferreira-Gonzalez A, Braziel R, Nolte F. AMP test directory. Bethesda, MD: Association for Molecular Pathology (Clinical Practice Committee), 1998.